Actinogen Medical Limited (ATGGF)
OTCMKTS
· Delayed Price · Currency is USD
0.0200
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT
Actinogen Medical Revenue
Actinogen Medical had revenue of 9.02M AUD in the twelve months ending December 31, 2024, up 88.25% year-over-year. In the fiscal year ending June 30, 2024, Actinogen Medical had annual revenue of 9.93M with 103.18% growth.
Revenue (ttm)
9.02M AUD
Revenue Growth
+88.25%
P/S Ratio
9.36
Revenue / Employee
1.50M AUD
Employees
6
Market Cap
52.26M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9.93M | 5.04M | 103.18% |
Jun 30, 2023 | 4.89M | 1.25M | 34.28% |
Jun 30, 2022 | 3.64M | 1.66M | 83.47% |
Jun 30, 2021 | 1.98M | -1.53M | -43.58% |
Jun 30, 2020 | 3.52M | -1.35M | -27.69% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |